Zobrazeno 1 - 10
of 769
pro vyhledávání: '"Jucker BM"'
Autor:
Solomon HM; Reproductive Toxicology, IVIVT, GSK, Collegeville, Pennsylvania, USA., Murzyn S; Reproductive Toxicology, IVIVT, GSK, Collegeville, Pennsylvania, USA., Rendemonti J; Reproductive Toxicology, IVIVT, GSK, Collegeville, Pennsylvania, USA., Chapman S; Reproductive Toxicology, IVIVT, GSK, Collegeville, Pennsylvania, USA., Cheng SH; Bioimaging, IVIVT, GSK, Collegeville, Pennsylvania, USA., Jucker BM; Bioimaging, IVIVT, GSK, Collegeville, Pennsylvania, USA., Stanislaus D; Reproductive Toxicology, IVIVT, GSK, Collegeville, Pennsylvania, USA., Gehman A; Research & MDS Statistics, GSK, Collegeville, Pennsylvania, USA., Alsaid H; Bioimaging, IVIVT, GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
Birth defects research [Birth Defects Res] 2023 Aug 15; Vol. 115 (14), pp. 1284-1293. Date of Electronic Publication: 2023 May 04.
Autor:
Alsaid H; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA. hasan.5.alsaid@gsk.com., Cheng SH; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Bi M; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Xie F; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Rambo M; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Skedzielewski T; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Hoang B; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Mohanan S; Non-Clinical Safety, IVIVT, GlaxoSmithKline, Collegeville, PA, USA., Comroe D; Integrated Biological Platform Sciences, GlaxoSmithKline, Collegeville, PA, USA., Gehman A; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Hsu CY; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Farhangi K; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Tran H; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Sherina V; Research Statistics, GlaxoSmithKline, Collegeville, PA, USA., Doan M; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Groseclose MR; Bioimaging, IVIVT, GlaxoSmithKline, Collegeville, PA, 19426, USA., Hopson CB; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Brett S; Oncology Cell Therapy Research Unit, GlaxoSmithKline, Hertfordshire, UK., Wilson IA; ImaginAb, Inglewood, CA, USA., Nicholls A; Bioimaging, IVIVT, GlaxoSmithKline, Hertfordshire, UK., Ballas M; Oncology Clinical Development, GlaxoSmithKline, Collegeville, PA, USA., Waight JD; Immuno-Oncology Research Unit, GlaxoSmithKline, Collegeville, PA, USA., Jucker BM; Clinical Imaging, GlaxoSmithKline, Collegeville, PA, USA.
Publikováno v:
Molecular imaging and biology [Mol Imaging Biol] 2023 Jun; Vol. 25 (3), pp. 528-540. Date of Electronic Publication: 2022 Oct 20.
Autor:
Madi S; Bioimaging, GSK, Collegeville, PA, United States., Xie F; Bioimaging, GSK, Collegeville, PA, United States., Farhangi K; Bioimaging, GSK, Collegeville, PA, United States., Hsu CY; Bioimaging, GSK, Collegeville, PA, United States., Cheng SH; Bioimaging, GSK, Collegeville, PA, United States., Aweda T; Bioimaging, GSK, Collegeville, PA, United States., Radaram B; Bioimaging, GSK, Collegeville, PA, United States., Slania S; Bioimaging, GSK, Collegeville, PA, United States., Lambert T; Non Clinical Safety, GSK, Collegeville, PA, United States., Rambo M; Bioimaging, GSK, Collegeville, PA, United States., Skedzielewski T; Bioimaging, GSK, Collegeville, PA, United States., Cole A; Research Statistics, GSK, Collegeville, PA, United States., Sherina V; Research Statistics, GSK, Collegeville, PA, United States., McKearnan S; Research Statistics, GSK, Collegeville, PA, United States., Tran H; Research Statistics, GSK, Collegeville, PA, United States., Alsaid H; Bioimaging, GSK, Collegeville, PA, United States., Doan M; Bioimaging, GSK, Collegeville, PA, United States., Stokes AH; Non Clinical Safety, GSK, Collegeville, PA, United States., O'Hagan DT; Vaccines Research & Development, GSK, Rockville, MD, United States., Maruggi G; Vaccines Research & Development, GSK, Rockville, MD, United States., Bertholet S; Vaccines Research & Development, GSK, Rockville, MD, United States., Temmerman ST; Vaccines Research & Development, GSK, Rixensart, Belgium., Johnson R; Vaccines Research & Development, GSK, Rockville, MD, United States., Jucker BM; Clinical Imaging, GSK, Collegeville, PA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jan 11; Vol. 13, pp. 1081156. Date of Electronic Publication: 2023 Jan 11 (Print Publication: 2022).
Multimodal imaging distribution assessment of a liposomal antibiotic in an infectious disease model.
Autor:
Cheng SH; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA. Electronic address: shih-hsun.x.cheng@gsk.com., Groseclose MR; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Mininger C; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Bergstrom M; Clinical imaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Zhang L; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Lenhard SC; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Skedzielewski T; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Kelley ZD; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Comroe D; In Vivo Science and Delivery, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Hong H; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Cui H; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA; Jemincare, Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai 201203, China., Hoover JL; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Rittenhouse S; Infectious disease Research Unit, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Castellino S; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA; Xenovista LLC, 3622 Travis Ct, Chapel Hill, NC 27516, USA., Jucker BM; Clinical imaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA., Alsaid H; Bioimaging, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA 19426-2990, USA. Electronic address: hasan.5.alsaid@gsk.com.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Dec; Vol. 352, pp. 199-210. Date of Electronic Publication: 2022 Oct 20.
Autor:
Jucker BM; GlaxoSmithKline, Collegeville, PA, USA., Fuchs EJ; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., Lee S; Amallis Consulting Ltd, London, UK., Damian V; GlaxoSmithKline, Collegeville, PA, USA., Galette P; GlaxoSmithKline, Collegeville, PA, USA., Janiczek R; GlaxoSmithKline, Collegeville, PA, USA., Macura KJ; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., Jacobs MA; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., Weld ED; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., Solaiyappan M; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., D'Amico R; ViiV Healthcare, Research Triangle Park, NC, USA., Shaik JS; GlaxoSmithKline, Collegeville, PA, USA., Bakshi K; GlaxoSmithKline, Collegeville, PA, USA., Han K; GlaxoSmithKline, Collegeville, PA, USA., Ford S; GlaxoSmithKline, Research Triangle Park, NC, USA., Margolis D; ViiV Healthcare, Research Triangle Park, NC, USA., Spreen W; ViiV Healthcare, Research Triangle Park, NC, USA., Gupta MK; GlaxoSmithKline, Collegeville, PA, USA., Hendrix CW; Departments of Internal Medicine and Radiology, The Johns Hopkins School of Medicine, Baltimore, MD, USA., Patel P; ViiV Healthcare, Research Triangle Park, NC, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Feb; Vol. 88 (4), pp. 1655-1666. Date of Electronic Publication: 2021 Jul 31.
Autor:
Savira F; Biomarker Discovery, Baker Heart and Diabetes Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Kompa AR; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Magaye R; Biomarker Discovery, Baker Heart and Diabetes Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Xiong X; Biomarker Discovery, Baker Heart and Diabetes Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Huang L; Biomarker Discovery, Baker Heart and Diabetes Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Jucker BM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Willette RN; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Wang BH; Biomarker Discovery, Baker Heart and Diabetes Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au.
Publikováno v:
Life sciences [Life Sci] 2021 May 01; Vol. 272, pp. 119267. Date of Electronic Publication: 2021 Feb 22.
Autor:
Savira F; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Kompa AR; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Edgley AJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Jucker BM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Willette RN; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Wang BH; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2021 Mar 01; Vol. 326, pp. 156. Date of Electronic Publication: 2020 Oct 17.
Autor:
Savira F; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Edgley AJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Jucker BM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Willette RN; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Krum H; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Kompa AR; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Wang BH; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2021 Jan 15; Vol. 323, pp. 260. Date of Electronic Publication: 2020 Sep 10.
Autor:
Savira F; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Kompa AR; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Edgley AJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Jucker BM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Willette RN; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Wang BH; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2020 Oct 01; Vol. 316, pp. 207.
Autor:
Savira F; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Wang BH; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu.au., Edgley AJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Jucker BM; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Willette RN; Heart Failure Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA., Krum H; Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia., Kompa AR; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia. Electronic address: andrew.kompa@unimelb.edu.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2020 Jul 01; Vol. 310, pp. 128-136. Date of Electronic Publication: 2020 Apr 06.